Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;100(4):101027.
doi: 10.1016/j.psj.2021.101027. Epub 2021 Jan 26.

ALV-J-contaminated commercial live vaccines induced pathogenicity in Three-Yellow chickens: one of the transmission routes of ALV-J to commercial chickens

Affiliations

ALV-J-contaminated commercial live vaccines induced pathogenicity in Three-Yellow chickens: one of the transmission routes of ALV-J to commercial chickens

Peikun Wang et al. Poult Sci. 2021 Apr.

Erratum in

Abstract

One avian leukosis virus of subgroup J (ALV-J) strain GX14YYA1 was isolated from a commercial bivalent Newcastle disease (ND)-infectious bronchitis (IB) vaccine in our previous study. To evaluate the pathogenicity of the ALV-J-contaminated vaccine on commercial chickens, day-old Three-Yellow chicks in group I were vaccinated with ALV-J-contaminated bivalent ND-IB live vaccine by intranasal and eye drop at 1-day-old for the primary vaccination and at 7-day-old for the secondary vaccination. Groups II and III were kept as the normal vaccination group with the noncontaminated ND-IB vaccine and blank control groups, respectively. The birds of different groups were maintained separately in isolators for 175 d. The first viremia was detected at 4 wk of age and 20% (2/10) of the birds maintained viremia during 11 to 25 wk of age. At the same time, the birds in group I experienced a significant suppression of body weight gain when compared with those of groups II and III (P < 0.05). In addition, the birds in group I showed obvious ALV-J hemangioma-type anatomical lesions in the liver and tumors were observed in the abdominal cavity. The results demonstrated that the ALV-J contaminated commercial live vaccines can induce pathogenicity in commercial Three-Yellow chickens and indicate that ALV-J-contaminated commercial live vaccines could be one of the transmission routes of ALV-J to commercial chickens.

Keywords: avian leukosis virus subgroup J; hemangioma; live vaccine; pathogenicity; transmission.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Viremia, PCR results, and the influence of ALV-J infection on the body weights of birds (X±SE). (A) Influence of the viral infection on the body weights of birds. Each mean body weight, followed by a different lower-case letter, was significantly different (P < 0.05) based on Duncan's multiple range test. (B) ALV-positive identification by ALV P27 antigen ELISA; an S/P value greater than or equal to 0.2 was regarded as positive. (C) PCR was used to identify the ALV-J in the samples of 10 birds. The results showed that all ALV-positive samples were ALV-J; C1-C4, PCR results of 28, 56, 77, and 175 d samples. M, DL2000 DNA marker; +, DF-1 cells infected with GX14YYA1 used as positive control; -, uninfected DF-1 cells used as a negative control; 1-10, samples. Abbreviation: ALV-J, avian leukosis virus of subgroup J.
Figure 2
Figure 2
Anatomical, histopathological lesions and sequence analysis results. (A) Hemangioma in the liver; (B) Blood cells and heterophilic lymphoid cells in the hemangioma region; (C) Tumor in the abdomen; (D) The infiltrated myelocytes that were characterized by acidophilic granules in the cytoplasm; (E) Comparison of normal (without arrow point) and abnormal testicles (with arrow point); (F) Ovaries poorly developed at 175-day-old; (G) Ovaries normally developed at 175-day-old. Similarity of nucleotide (H1) and amino acids (H2) sequences of gp85 between GX14YYA1-J3, GX14YYA1-J5 and GX14YYA1; (I) Comparison of the amino acid sequences of gp85 between GX14YYA1-J3, GX14YYA1-J5, and GX14YYA1.

References

    1. Dai M.M., Li S.B., Shi K.Y., Liao J.Y., Hui S., Liao M. Systematic identification of host Immune Key Factors influencing viral infection in PBL of ALV-J infected SPF chicken. Viruses. 2020;12:114. - PMC - PubMed
    1. Du Y., Cui Z.Z., Qin A.J., Silva R.F., Lee L.F. Isoaltion of Subgroup J avian leukosis viruses and their partial sequence comparison. Chin. J. Virol. 2000;6:341–346.
    1. Fadly A., Pandiri R. Silva.A., Davis C. Isolation and characterization of an Adventitious avian leukosis virus isolated from commercial Marek's disease vaccines. Avian Dis. 2006;50:380–385. - PubMed
    1. Guan X., Zhang Y., Yu M., Ren C., Gao Y., Yun B., Liu Y., Wang Y., Qi X., Liu C., Cui H., Zhang Y., Gao L., Li K., Pan Q., Zhang B., Wang X., Gao Y. Residues 28 to 39 of the Extracellular Loop 1 of chicken Na+/H+ Exchanger type I Mediate cell Binding and Entry of subgroup J avian leukosis virus. J. Virol. 2017;92 e01627-17. - PMC - PubMed
    1. Li H.J., Wang P.K., Lin L.L., Shi M.Y., Gu Z.M., Huang T., Mo M.L., Wei T.C., Zhang H.M., Wei P. The emergence of the infection of subgroup J avian leucosis virus escalated the tumour incidence in commercial Yellow chickens in Southern China in recent years. Transbound. Emerg. Dis. 2019;66:312–316. - PubMed